ResearchOptimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer
ResearchExtended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study
ResearchFrom a cancer survivorship-focused continuing medical education course to practice change implementation: results of a provider survey
ResearchHormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial
ResearchImpact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial
ResearchCombined intermittent fasting and exercise intervention in patients with metastatic, hormone receptor-positive breast cancer (FastER): a pilot study
ResearchSurvival deficits in young women with breast cancer in sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort
ResearchEfficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial
Jul 27, 2025Journal ArticlePatient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study.Written by 2 Roon authors & 16 others Via Annals of Surgical Oncology
ResearchFertility preservation and fertility treatment use in young breast cancer survivors reporting a live birth
ResearchAssociation of cancer treatment with excess heart age among five-year young breast cancer survivors